BIOMAT Database Logo BIOMAT Database Logo

Human mesangial cell production of monocyte chemoattractant protein-1: modulation by lovastatin. 1995

S Y Kim, and C Guijarro, and M P O'Donnell, and B L Kasiske, and Y Kim, and W F Keane
Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota, USA.

Macrophages play a critical role in the progression of clinical and experimental glomerular injury. Serum-stimulated human fetal mesangial cells in culture produce a chemotactic factor that is monocyte-selective. This chemotactic factor is most likely monocyte chemoattractant protein-1 (MCP-1) as a monoclonal antibody directed against MCP-1, but not an irrelevant antibody, suppressed the mesangial cell-derived chemotactic activity. Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase by lovastatin resulted in a reduction of the mesangial cell-derived chemotactic activity as well as MCP-1 mRNA expression. The inhibitory effects of lovastatin in the presence of exogenous cholesterol were reversed by mevalonate, suggesting a role for isoprenoid intermediates of the mevalonate pathway and/or isoprenylated proteins in mesangial cell MCP-1 regulation. These findings suggest an additional mechanism by which HMG-CoA reductase inhibition in vivo may reduce glomerular injury.

UI MeSH Term Description Entries
D008148 Lovastatin A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver. Lovastatin, 1 alpha-Isomer,Mevinolin,6-Methylcompactin,Lovastatin, (1 alpha(S*))-Isomer,MK-803,Mevacor,Monacolin K,1 alpha-Isomer Lovastatin,6 Methylcompactin,Lovastatin, 1 alpha Isomer,MK 803,MK803,alpha-Isomer Lovastatin, 1
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005920 Glomerular Mesangium The thin membranous structure supporting the adjoining glomerular capillaries. It is composed of GLOMERULAR MESANGIAL CELLS and their EXTRACELLULAR MATRIX. Mesangium, Glomerular,Mesangial Extracellular Matrix,Extracellular Matrices, Mesangial,Extracellular Matrix, Mesangial,Glomerular Mesangiums,Matrices, Mesangial Extracellular,Matrix, Mesangial Extracellular,Mesangial Extracellular Matrices,Mesangiums, Glomerular
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D018932 Chemokine CCL2 A chemokine that is a chemoattractant for MONOCYTES and may also cause cellular activation of specific functions related to host defense. It is produced by LEUKOCYTES of both monocyte and lymphocyte lineage and by FIBROBLASTS during tissue injury. It has specificity for CCR2 RECEPTORS. Monocyte Chemoattractant Protein-1,Monocyte Chemotactic Protein-1,CCL2 Chemokine,Chemokine (C-C Motif) Ligand 2,Chemokines CCL2,Monocyte Chemotactic and Activating Factor,CCL2, Chemokine,CCL2, Chemokines,Chemoattractant Protein-1, Monocyte,Chemokine, CCL2,Chemotactic Protein-1, Monocyte,Monocyte Chemoattractant Protein 1,Monocyte Chemotactic Protein 1
D019161 Hydroxymethylglutaryl-CoA Reductase Inhibitors Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. HMG-CoA Reductase Inhibitor,HMG-CoA Reductase Inhibitors,Hydroxymethylglutaryl-CoA Reductase Inhibitor,Statin,Statins, HMG-CoA,Inhibitors, HMG-CoA Reductase,Inhibitors, Hydroxymethylglutaryl-CoA,Inhibitors, Hydroxymethylglutaryl-Coenzyme A,Statins,HMG CoA Reductase Inhibitor,HMG CoA Reductase Inhibitors,HMG-CoA Statins,Hydroxymethylglutaryl CoA Reductase Inhibitor,Hydroxymethylglutaryl CoA Reductase Inhibitors,Hydroxymethylglutaryl-CoA Inhibitors,Hydroxymethylglutaryl-Coenzyme A Inhibitors,Inhibitors, HMG CoA Reductase,Inhibitors, Hydroxymethylglutaryl CoA,Inhibitors, Hydroxymethylglutaryl Coenzyme A,Inhibitors, Hydroxymethylglutaryl-CoA Reductase,Reductase Inhibitor, Hydroxymethylglutaryl-CoA,Reductase Inhibitors, HMG-CoA,Reductase Inhibitors, Hydroxymethylglutaryl-CoA,Statins, HMG CoA

Related Publications

S Y Kim, and C Guijarro, and M P O'Donnell, and B L Kasiske, and Y Kim, and W F Keane
Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells.
April 1992, Journal of immunology (Baltimore, Md. : 1950),
S Y Kim, and C Guijarro, and M P O'Donnell, and B L Kasiske, and Y Kim, and W F Keane
Lipopolysaccharide induces monocyte chemoattractant protein production by rat mesangial cells.
July 1994, The Journal of laboratory and clinical medicine,
S Y Kim, and C Guijarro, and M P O'Donnell, and B L Kasiske, and Y Kim, and W F Keane
Dual effects of endothelin-1 (1-31): induction of mesangial cell migration and facilitation of monocyte recruitment through monocyte chemoattractant protein-1 production by mesangial cells.
June 2004, Hypertension research : official journal of the Japanese Society of Hypertension,
S Y Kim, and C Guijarro, and M P O'Donnell, and B L Kasiske, and Y Kim, and W F Keane
Monocyte chemoattractant protein-1 production by human detrusor smooth muscle cells.
January 2004, The Journal of urology,
S Y Kim, and C Guijarro, and M P O'Donnell, and B L Kasiske, and Y Kim, and W F Keane
Human monocyte chemoattractant protein-1 (MCP-1).
January 1991, Advances in experimental medicine and biology,
S Y Kim, and C Guijarro, and M P O'Donnell, and B L Kasiske, and Y Kim, and W F Keane
Human monocyte chemoattractant protein-1 (MCP-1).
March 1990, Immunology today,
S Y Kim, and C Guijarro, and M P O'Donnell, and B L Kasiske, and Y Kim, and W F Keane
Modulation of macrophage recruitment into wounds by monocyte chemoattractant protein-1.
January 2001, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society,
S Y Kim, and C Guijarro, and M P O'Donnell, and B L Kasiske, and Y Kim, and W F Keane
PARK2 mediates interleukin 6 and monocyte chemoattractant protein 1 production by human macrophages.
January 2013, PLoS neglected tropical diseases,
S Y Kim, and C Guijarro, and M P O'Donnell, and B L Kasiske, and Y Kim, and W F Keane
Hypoxia selectively inhibits monocyte chemoattractant protein-1 production by macrophages.
February 2004, Journal of immunology (Baltimore, Md. : 1950),
S Y Kim, and C Guijarro, and M P O'Donnell, and B L Kasiske, and Y Kim, and W F Keane
Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody.
May 1993, Human pathology,
Copied contents to your clipboard!